Reglagene is an oncology company focused on discovering and developing novel medicines for difficult to treat and metastatic cancers. Reglagene’s first product is indicated for CNS cancers, including primary and secondary brain cancers. There is a massive unmet medical need in this therapeutic area. Reglagene’s first product is therapeutically effective, well tolerated, orally administered, and can freely cross the blood-brain barrier.